CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $82,244
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$82,244. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-01 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2026-04-06 | GILL JOHN Director | Purchase | +9,200 | $3.41 | $31K | 21,700 |
| 2025-12-23 | GILL JOHN Director | Purchase | +12,500 | $4.10 | $51K | 12,500 |
| 2025-09-25 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2024-09-26 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +34,900 | 34,900 | ||
| 2023-09-28 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +26,100 | 26,100 | ||
| 2022-09-29 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +23,500 | 23,500 | ||
| 2022-08-12 | GILL JOHN Director | Sale | −2,714 | $15.00 | $41K | 2,771 |
| 2022-01-06 | GILL JOHN Director | Gift | −2,714 | 0 | ||
| 2021-09-23 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +24,100 | 24,100 | ||
| 2020-11-30 | GILL JOHN Director | Sale | −8,425 | $11.92 | $100K | 11,199 |
| 2020-09-24 | GILL JOHN Director | Option exercise | +16,850 | 19,624 | ||
| 2020-09-24 | GILL JOHN Director | Option exercise · Restricted Stock Units ("RSUs") | −16,850 | 0 | ||
| 2020-09-24 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +25,500 | 25,500 | ||
| 2020-06-25 | GILL JOHN Director | Grant or award · Restricted Stock Units ("RSUs") | +16,850 | 16,850 | ||
| 2019-01-02 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +20,000 | 20,000 | ||
| 2017-10-13 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +20,000 | 20,000 | ||
| 2017-06-02 | GILL JOHN Director | Purchase | +1,000 | $4.34 | $4K | 83,224 |
| 2016-11-22 | GILL JOHN President and CEO | Option exercise | +100,000 | $2.20 | $220K | 822,244 |
| 2016-11-22 | GILL JOHN President and CEO | Option exercise · Employee Stock Option (right to buy) | −100,000 | 0 |
Page 1 of 2 · 37 trades